Bio-Rad Laboratories (BIO) Earnings Date, Estimates & Call Transcripts $332.91 +7.33 (+2.25%) (As of 11/22/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Bio-Rad Laboratories Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 20EstimatedActual EPS (Oct. 30) $2.01 Beat By $0.85 Consensus EPS (Oct. 30) $1.16 Bio-Rad Laboratories released Q3 2024 earnings on October 30, 2024, reporting an EPS of $2.01, which topped analysts' consensus estimates of $1.16 by $0.85. Quarterly revenue rose 2.8% year-over-year to $649.70 million, above the consensus estimate of $628.18 million. With a trailing EPS of -$27.33, Bio-Rad Laboratories' earnings are expected to grow 15.71% next year, from $9.93 to $11.49 per share. Conference Call TranscriptConference Call AudioSEC 10-Q/10-K FilingBIO Upcoming EarningsBio-Rad Laboratories' next earnings date is estimated for Thursday, February 20, 2025, based off prior year's reporting schedules. Get Bio-Rad Laboratories Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bio-Rad Laboratories and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBIO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BIO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyFinancial Prophecy The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy. Bio-Rad Laboratories Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241$2.06$2.06$2.06Q2 20241$2.03$2.03$2.03Q3 20241$1.28$1.28$1.28Q4 20241$2.77$2.77$2.77FY 20244$8.14$8.14$8.14Q1 20251$2.34$2.34$2.34Q2 20251$2.87$2.87$2.87Q3 20251$2.94$2.94$2.94Q4 20251$2.97$2.97$2.97FY 20254$11.12$11.12$11.12Q1 20261$3.31$3.31$3.31Q2 20261$3.25$3.25$3.25Q3 20261$2.90$2.90$2.90 Bio-Rad Laboratories Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/20/2025(Estimated)------- 10/30/2024Q3 2024$1.16$2.01+$0.85-$19.32$628.18M$649.70M 8/1/2024Q2 2024$2.12$3.11+$0.99$82.48$645.79M$638.50M 5/7/2024Q1 2024$2.04$2.29+$0.25-$8.87$619.09M$610.82M 2/15/2024Q4 2023$2.93$3.10+$0.17-$5.94$685.00M$681.18M 10/26/2023Q3 2023$2.87$2.33 -$0.54$1.02$689.50M$632.10M 8/3/2023Q2 2023$2.55$3.00+$0.45$45.59$697.96M$681.10M Get the Latest News and Ratings for BIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter. 5/4/2023Q1 2023$3.24$3.34+$0.10$4.36$689.28M$676.80M 2/16/2023Q4 2022$3.45$3.31 -$0.14-$21.16$741.01M$730.29M Bio-Rad Laboratories Earnings - Frequently Asked Questions When is Bio-Rad Laboratories's earnings date? Bio-Rad Laboratories has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates. Learn more on BIO's earnings history. What guidance has Bio-Rad Laboratories issued on next quarter's earnings? Bio-Rad Laboratories issued an update on its FY 2024 earnings guidance on Wednesday, October, 30th. The company issued revenue guidance of $2.6 billion-$2.6 billion, compared to the consensus revenue estimate of $2.6 billion. Did Bio-Rad Laboratories beat their earnings estimates last quarter? In the previous quarter, Bio-Rad Laboratories (NYSE:BIO) reported $2.01 earnings per share (EPS) to beat the analysts' consensus estimate of $1.16 by $0.85. Learn more on analysts' earnings estimate vs. BIO's actual earnings. How can I listen to Bio-Rad Laboratories's earnings conference call? The conference call for Bio-Rad Laboratories's latest earnings report can be listened to online. Listen to Conference Call How can I read Bio-Rad Laboratories's conference call transcript? The conference call transcript for Bio-Rad Laboratories's latest earnings report can be read online. Read Transcript How can I view Bio-Rad Laboratories's earnings report? Bio-Rad Laboratories's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Bio-Rad Laboratories generate each year? Bio-Rad Laboratories (NYSE:BIO) has a recorded annual revenue of $2.67 billion. How much profit does Bio-Rad Laboratories generate each year? Bio-Rad Laboratories (NYSE:BIO) has a recorded net income of -$637.32 million. BIO has generated -$27.33 earnings per share over the last four quarters. What is Bio-Rad Laboratories's EPS forecast for next year? Bio-Rad Laboratories's earnings are expected to grow from $9.93 per share to $11.49 per share in the next year, which is a 15.71% increase. ` More Earnings Resources from MarketBeat Related Companies MTD Earnings WAT Earnings ILMN Earnings TECH Earnings CRL Earnings BRKR Earnings PACB Earnings HBIO Earnings TMO Earnings A Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report Financial Prophecy (Ad)The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy. This page (NYSE:BIO) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIO Stock Alerts